Folic acid for the prevention of neural tube defects

Pediatrics

Volumn 104, Issue 2 I, 1999, Pages 325-327

  Desposito, F ^a   Cunniff, C ^a   Frias, J L ^a   Panny, S R ^a   Trotter, T L ^a   Wappner, R S ^a   Hanson, J W ^a   Elias, S ^a   Moore, C A ^a   Lloyd Puryear, M ^a   De la Cruz, F ^a   Pletcher, B A ^a   Cho, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; CONCEPTION; DIET SUPPLEMENTATION; HUMAN; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPINA BIFIDA;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; PREGNANCY;

EID: 0032815311     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.2.325     Document Type: Review

References (18)

1. Centers for Disease Control and Prevention. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis. United States, 1985-1994. MMWR. 1996;44(SS-4):1-13
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991; 338:131-137
3. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835
4. Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects: 1983-1991. MMWR. 1991;40:513-516
5. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 1992;41:1-8
6. Forrest JD. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol. 1994;170:1485-1489
7. Moore KL. Formulation of the trilaminar embryo. In: The Developing Human. Philadelphia, PA: WB Saunders Co; 1988:55-64
8. Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age - United States, 1995 and 1998. MMWR. 1999;48:325-327
9. Hall JG, Solehdin F. Genetics of neural tube defects. Ment Retard Dev Disabil. 1999;4:269-281
10. Smithells RW, Nevin NC, Seller MJ, et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1983;1:1027-1031
11. Cornel MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly. Teratology. 1997;55:134-137
12. Bailey LB. Folate requirements and dietary recommendations. In: Bailey LB, ed. Folate in Health and Disease. New York, NY: Marcel Dekker, Inc; 1995:123-151
13. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA. 1995;274: 1698-1702
14. Institute of Medicine. Dietary reference intakes: folate, other B vitamins, and choline. In: Dietary Reference Intakes for Thiamin, Riboflavin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acta, Biotin, and Choline. Washington, DC: National Academy Press; 1998:(8)32
15. US Department of Health and Human Services, Food and Drug Administration. Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1996;61:8781-8807
16. 12. Am J Clin Nutr. 1997;65:1889-1890
17. Oakley GP Jr, Erickson JD. Vitamin A and birth defects: continuing caution is needed. N Engl J Med. 1995;333:1414-1415
18. Tolmie J. Neural tube defects and other congenital malformations of the central nervous system. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin's Principles and Practice of Medical Genetics. New York, NY: Churchill Livingstone Inc; 1997:2145-2176